Global Wearable Injectors Market - Strategic Insights and Forecasts (2026-2031)

The global wearable injectors market is forecast to grow at a CAGR of 19.7%, reaching USD 29.9 billion in 2031 from USD 12.2 billion in 2026.

Wearable injectors are medical devices used for drug delivery systems. It is attached to the patient to deliver the drugs in a controlled manner. For the same reason, the devices are also called patch pumps or patch injectors.  These devices are typically used for high-volume medications, drugs with high viscosities, and medicines that are required at regular intervals over a long period. The device reduces the need for multiple painful injections, making it convenient and user-friendly.

Wearable injectors are easy to use, especially when regular intervals of medication are required, thus providing a significant advantage over manual injections. The growing prevalence of chronic diseases and changing lifestyles around the globe are considered the key drivers for the global wearable injector market growth.

The wearable injectors are user-friendly, making them easy to self-administer. They also do not interfere with the user's day-to-day life.  These devices improve dose accuracy and prevent needlestick injuries. Furthermore, rising healthcare costs and changes in technology have led to innovative solutions that are efficient for managing the disease and also reduce the number of trips to hospitals and clinics to receive medical support for an injection.

Wearable Injectors Market Growth Drivers:

• Increasing number of chronic diseases and lifestyle changes are anticipated in the market growth.

Chronic or non-communicable diseases like cancer, hypertension, diabetes, cardiovascular diseases, etc., are the leading causes of death globally. According to the World Health Organisation (WHO), 71% of all deaths are due to non-communicable diseases (NCDs). Globally, 17.9 million people are diseased due to cardiovascular disease annually. This is followed by cancer, respiratory diseases, and diabetes, accounting for 9.3 million, 4.1 million, and 1.5 million deaths, respectively.

Wearable injectors play an important role in managing non-communicable diseases like cardiovascular disease, cancer, diabetes, and autoimmune disease, amongst other diseases. In particular, with the growing sedentary lifestyle. These injectors are highly used devices to deliver drugs prescribed by the doctor at regular intervals. This eliminates the possibility of the drug being over- or underdosed. Not only is it user-friendly, but it also saves time and money by reducing the number of trips to hospitals for medical assistance for injections.

• Technological advancement and increasing awareness are anticipated in the market growth.

With the increase in awareness of health, precautionary measures, and increased research and development in the medical industry, solutions like wearable injectors play an important role in assisting with various non-communicable diseases. As individuals are becoming more health-conscious, they are not just becoming aware of diseases but of all the alternative treatments and medical devices that are available for the management of such diseases.  

Wearable infusion pumps are lightweight, compact devices that patients wear on their belts with an attached cannula on their skin. These off-body injectors are ideal for patients requiring continuous or intermittent infusions over an extended period, allowing them to move freely during treatment. Most insulin pumps are worn on the belt, connected to the infusion set in subcutaneous fatty tissue.

Several steps are taken by governments and international organizations to raise awareness amongst the citizens to ensure that timely assistance is provided. Further, with technological advancement, the manufacturing cost has been reduced significantly. By using highly advanced automation, companies can reach economies of scale. Increasing profits and focusing more on R&D for better solutions are also priorities.

Wearable Injectors Market Restraints:

• Environmental concerns could hamper the market growth.

Though wearable injectors are life-saving devices, they come at a cost to the environment. These devices are made of plastic bodies and are manufactured for one-time use purposes. Mishandling of devices and their improper disposal can also be hazardous.  Since these devices need proper disposal and not all countries have a good disposal system, this not only affects other humans but also the ecosystem, as plastic takes a long time to decompose.

Wearable Injectors Market Key Developments:

• April 2026: Modular Medical received FDA 510(k) clearance for the Pivot™ tubeless insulin patch pump, featuring a removable two-part wearable injector design for insulin-dependent diabetes patients.

• February 2026: Insulet Corporation launched the Omnipod® 5 automated insulin delivery system and Omnipod Discover™ platform across Middle Eastern markets, expanding wearable insulin management solutions.

• November 2025: Modular Medical, Inc. submitted its Pivot™ tubeless insulin patch pump for FDA 510(k) clearance, targeting simplified wearable insulin delivery for diabetes management.

• August 2025: Enable Injections received ANVISA approval in Brazil and MHRA registration in the UK for its enFuse® on-body wearable drug delivery system platform.

• July 2025: BD (Becton, Dickinson and Company) announced the first pharma-sponsored clinical trial using the BD Libertas™ wearable injector platform for subcutaneous biologic drug delivery applications.

• June 2025: Sanofi presented positive Phase 3 IRAKLIA data supporting subcutaneous Sarclisa administration using Enable Injections’ enFuse® wearable on-body injector for multiple myeloma treatment.

List of Top Wearable Injectors Companies:

• Medtronic

• Amgen (Acquired by tenebio)

• Ypsomed

• Insulet Corporation

• West Pharmaceutical Services

Wearable Injectors Market Scope: